Neuroendovascular Coil Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company's Neuroendovascular Coil Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LANDON, GREATER LANDON, UK, June 26, 2024 /EINPresswire.com/ -- The neuroendovascular coil market is expected to grow from $1.18 billion in 2023 to $1.29 billion in 2024, at a compound annual growth rate (CAGR) of 9.3%. Despite recent challenges, the market is projected to reach $1.74 billion by 2028, driven by the continuous rise in neurovascular cases and advancements in neurointerventional technologies.

Growing Prevalence of Neurovascular Diseases Propels Market Growth
The increasing prevalence of neurovascular diseases is a significant factor contributing to the growth of the neuroendovascular coil market. These conditions, which affect the blood vessels supplying the nervous system, can lead to severe neurological complications. Neuroendovascular coils are essential in treating these diseases by blocking or stabilizing abnormal blood vessel structures, thereby reducing the risk of bleeding or other complications. For instance, the Centers for Disease Control and Prevention reported an increase in stroke deaths from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021. With over 795,000 strokes occurring annually in the United States, the demand for effective neuroendovascular treatments continues to rise.

Explore comprehensive insights into the global neuroendovascular coil market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13495&type=smp

Key Players and Market Trends
Major companies in the neuroendovascular coil market, such as Cardinal Health Inc., Johnson & Johnson Services Inc., Medtronic PLC, and Stryker Corporation, are focused on product innovation. These companies are developing soft and uniquely-shaped coils to enhance the efficacy and safety of neuroendovascular procedures. For example, in December 2022, Stryker Corporation launched the Target Tetra Detachable Coil. This new product features a tetrahedral shape and softness level designed specifically for treating small aneurysms, providing stability in wide-necked aneurysms and a soft helical tail for improved treatment outcomes.

Segments:
• Product Type: Guglielmi Detachable Coils (GDCs), Matrix Coils
• Indication: Ruptured Aneurysm, Unruptured Aneurysm
• Application: Tumor Surgery, Medical Teaching
• End User: Hospitals, Ambulatory Surgical Centers (ASCs), Stroke Centers, Other End Users

Regional Insights: North America Leading the Market
North America was the largest region in the neuroendovascular coil market in 2023. The region's dominance is due to the high incidence of neurovascular diseases and advanced healthcare infrastructure. Meanwhile, Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by expanding neurointerventional services and increasing awareness of early intervention strategies.

Make your report purchase here and explore the whole industry's data as well: https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report

Neuroendovascular Coil Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Neuroendovascular Coil Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on neuroendovascular coil market size, neuroendovascular coil market drivers and trends, neuroendovascular coil market major players, competitors' revenues, market positioning, and market growth across geographies. The neuroendovascular coil market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Neuropathic Pain Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Neurotrophic Keratitis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Neurofibromatosis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.